Registered entities
Abcellera Biologics Inc.
Reg. No. 1703057United States
Innovation
8 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 236 times.
| Year | Filings |
|---|---|
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 4 |
Social engagement
Social engagement: 44.6K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
18 investors on record; lead investors include Orbimed, DCVC.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 50% |
| Private equity | 3 | 17% |
| Accelerator & incubator | 1 | 6% |
| Other / undisclosed | 5 | 28% |
Hiring activity
Hires periodically
8 roles tracked across 3 of the last 12 months
20 Jan 2026 · GxP QA Training & Compliance Specialist · Vancouver
8 Dec 2025 · Logistics · Vancouver
24 Nov 2025 · Medical Sciences · Vancouver
24 Nov 2025 · Quality Control · Vancouver
12 Nov 2025 · Quality Assurance Operations · Vancouver
Based on job postings tracked across public sources.
Recent activity
17 Jun 2026
Partnership
Jazz Pharmaceuticals and AbCellera
5 Jun 2026
Leadership hire
Board of Directors
7 May 2026
Event
Upcoming Investor Conferences